J&J backs two biotech startups, inaugurates innovation center

Johnson & Johnson's Boston Innovation Center officially opened as the company announced two more investments in biotech startups in the area. The Cambridge, MA, center is one of four planned by J&J. Report

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.